Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant
NCT ID: NCT01993862
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
266 participants
INTERVENTIONAL
2014-03-17
2016-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators
NCT01963286
Same Day Discharge
NCT02943512
T-ICD vs S-ICD Shocks: Myocardial Injuries
NCT03458065
A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
NCT03374891
Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
NCT02121158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization is assigned in a 1:1 ratio between the NDD group and the SDD group. Patients will undergo study evaluations after implant, pre-discharge, 1-week and 6 months post implant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Next Day Discharge
The patient will have a 23 hour standard of care observational stay in the hospital after an implantable cardioverter defibrillator implant procedure.
No interventions assigned to this group
Same Day Discharge
The patient will be discharged from the hospital the same evening after an implantable cardioverter defibrillator implant procedure. Follow up after surgery will be done via remote device follow up (1) on the day of discharge and (2) 24 hours after surgery.
Same Day Discharge
Patients will send device data remotely to their physician on the day of discharge from the hospital and again 24 hours after discharge from the hospital.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Same Day Discharge
Patients will send device data remotely to their physician on the day of discharge from the hospital and again 24 hours after discharge from the hospital.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is receiving an implantable cardioverter defibrillator for primary prevention
* Patient lives within 50 miles of an emergency room or 24 hour urgent care
* Patient is able to sign informed consent
Exclusion Criteria
* Physician elects to keep the patient in over night due to a change in medical condition or a pre-existing condition that requires administration of continuous blood thinners
* Physician is unable to program the implantable cardioverter defibrillator to collect all required information remotely from device
* Patient is pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Indrajit Choudhuri, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Ranjit Suri, MD
Role: PRINCIPAL_INVESTIGATOR
Heart Rhythm Associates of New York, NY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Center Research
Huntsville, Alabama, United States
Cardiology Associates of Mobile
Mobile, Alabama, United States
John C Lincoln North Mountain Hospital
Phoenix, Arizona, United States
Chula Vista Cardiac Center
Chula Vista, California, United States
Cardiovascular Consultants Heart Center
Fresno, California, United States
Stanislaus Cardiology Group
Modesto, California, United States
Sutter Medical Center of Santa Rosa
Santa Rosa, California, United States
Exempla Rocky Mountain Cardiovascular Associates
Broomfield, Colorado, United States
South Denver Cardiology Associates PC
Littleton, Colorado, United States
Lakeland Regional Medical Center
Lakeland, Florida, United States
Watson Clinic Center
Lakeland, Florida, United States
Florida Cardiovascular Specialists
Leesburg, Florida, United States
Naples Heart Rhythm Specialists, PA
Naples, Florida, United States
Loyola University Medical Center
Maywood, Illinois, United States
Chicago Cardiology Institute
Schaumburg, Illinois, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
Delmarva Heart
Salisbury, Maryland, United States
Thoracic Cardiovascular Healthcare Foundation
Lansing, Michigan, United States
Great Lakes Heart and Cascular Institute PC
Saint Joseph, Michigan, United States
Jackson Heart Clinic
Jackson, Mississippi, United States
Missouri Baptist Medical Center
St Louis, Missouri, United States
St. Louis Heart and Vascular PC
St Louis, Missouri, United States
The New York Hospital Queens
Flushing, New York, United States
St. Luke's Hospital - Roosevelt
New York, New York, United States
Cary Cardiology, PA
Cary, North Carolina, United States
Cardiology Consultants
Johnson City, Tennessee, United States
Arrhythmia Associates of South Texas
San Antonio, Texas, United States
Aurora Medical Group
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40009529/B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.